Center for Biotechnology and Interdisciplinary Studies (CBIS)

Rensselaer Experiment Tested on Zero-Gravity Flight

Amir Hirsa, a professor of mechanical, aerospace, and nuclear engineering at Rensselaer Polytechnic Institute, has developed a device that could yield valuable insights about the fluid mechanics at play in diseases like diabetes, Alzheimer’s, and Parkinson’s. 

Self-Built Protein Coatings Could Improve Biomedical Devices

Fouling is a natural phenomenon that describes the tendency of proteins in water to adhere to nearby surfaces. It’s what causes unwanted deposits of protein to form during some food production or on biomedical implants, causing them to fail. Researchers at Rensselaer Polytechnic Institute are harnessing this process, which is typically considered a persistent challenge, to develop a versatile and accessible approach for modifying solid surfaces.

Polymerized Estrogen Provides Neuroprotection in Preclinical Testing

A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury — preventing further damage. This promising result, found in a preclinical model, was recently published in ACS Chemical Neuroscience, and it lays the groundwork for further advancement of this new biomaterial.  

In Era of Online Learning, New Testing Method Aims To Reduce Cheating

The era of widespread remote learning brought about by the COVID-19 pandemic requires online testing methods that effectively prevent cheating, especially in the form of collusion among students. With concerns about cheating on the rise across the country, a solution that also maintains student privacy is particularly valuable.

Jonathan Dordick Elected to National Academy of Engineering

TROY, N.Y. — Jonathan Dordick, the Howard P. Isermann ’42 Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, has been elected to the National Academy of Engineering (NAE), for his “contributions to methods for rapidly screening drug efficacy and toxicity, and biocatalytic technologies for improving human health.”

Back to top